MONOGRAM TECHNOLOGIES INC., and EQUITY STOCK TRANSFER, LLC, as Warrant Agent [FORM OF] Warrant Agency Agreement Dated as of July 9, 2024Warrant Agency Agreement • July 12th, 2024 • Monogram Technologies Inc. • Surgical & medical instruments & apparatus • Delaware
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES, AND NO PUBLIC MARKET IS EXPECTED TO DEVELOP FOLLOWING THIS OFFERING.
Monogram Technologies Inc. Offering of up to 4,444,445 units Each unit consisting of one share of 8.00% Series D Convertible Cumulative Preferred Stock (the “Series D Preferred Stock”) and one Common Stock Purchase Warrant SELLING AGENCY AGREEMENTSelling Agency Agreement • July 12th, 2024 • Monogram Technologies Inc. • Surgical & medical instruments & apparatus • New York
Monogram Technologies Inc., a Delaware corporation (the “Company”), will offer to investors deemed suitable pursuant to the standards set forth in FINRA (as defined below) Rule 2111 through a registered ongoing offering (the “Offering”) up to a maximum of 4,444,445 units (the “Units”), with each unit consisting of one share of the Company’s 8.00% Series D Convertible Cumulative Preferred Stock (the “Series D Preferred Stock”) and one common stock purchase warrant (the “Warrants”) to purchase one share of the Company’s common stock, $0.001 par value per share (the “Common Stock”), for a total of 4,444,445 shares of the Company’s Series D Preferred Stock and warrants to purchase up to an aggregate 4,444,445 shares of the Company’s Common Stock, at an offering price of $2.25 per unit, for a maximum offering amount of $10,000,000 to investors (collectively, the “Investors.” The Units shall be offered and sold on the terms and conditions set forth in the Company’s registration statement on
MONOGRAM TECHNOLOGIES INC PUBLIC OFFERING SUBSCRIPTION AGREEMENT Units consisting of one share of 8.00% Series D Convertible Cumulative Preferred Stock and one Common Stock Purchase WarrantPublic Offering Subscription Agreement • July 12th, 2024 • Monogram Technologies Inc. • Surgical & medical instruments & apparatus
Monogram Technologies Inc. (the “Company”) is offering up to a maximum of 4,444,445 units (each a “Unit” and collectively, the “Units”) consisting of one share of 8.00% Series D Convertible Cumulative Preferred Stock (the “Series D Preferred Stock”) and one Common Stock Purchase Warrant (the “Warrant”).
